Helicobacter pylori seropositivities and risk of pancreatic carcinoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 1, 2014, Pages 172-178

  Risch, Harvey A ^a   Lu, Lingeng ^a   Kidd, Mark S ^b   Wang, Jing ^c   Zhang, Wei ^c   Ni, Quanxing ^d   Gao, Yu Tang ^c   Yu, Herbert ^e  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d FUDAN UNIVERSITY   (China)

^e UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CANCER RISK; CHINA; CONTROLLED STUDY; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; SERODIAGNOSIS; VEIN PUNCTURE;

ADULT; AGED; CASE-CONTROL STUDIES; CHINA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RISK FACTORS;

EID: 84892717732     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0447     Document Type: Article

References (30)

1. Gao Y-T, Lu W. Cancer incidence, mortality and survival rates in urban Shanghai (1973-2000). Shanghai: Second Military Medical University Press; 2007.
2. Risch HA. Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Natl Cancer Inst 2003;95:948-60.
3. Risch HA, Yu H, Lu L, Kidd MS ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst 2010;102:502-5.
4. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006;19:449-90.
5. Shu H, Ge Z, Xiang Z, Liu Y, Ren W, Xiao S. Evaluation of detecting methods of Helicobacter pylori infection-histology, serology, 13C urea breath test, and rapid urease tests. Chin J Digestion 1998;18: 260-2.
6. Shen J, Zhang N. The diagnostic significance of measurement of HMCAP in H. pylori infection. Chin J Gastroenterol Hepatol 2002;11:77-8.
7. Peters TM, Owen RJ, Slater E, Varea R, Teare EL, Saverymuttu S. Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsia. J Clin Pathol 2001;54:219-23.
8. Kumagai T, Malaty HM, Graham DY, Hosogaya S, Misawa K, Furihata K, et al. Acquisition versus loss of Helicobacter pylori infection in Japan: results from an 8-year birth cohort study. J Infect Dis 1998;178: 717-21.
9. Rosenstock S, Jørgensen T, Andersen L, Bonnevie O. Seroconversion and seroreversion in IgG antibodies to Helicobacter pylori: a serology based prospective cohort study. J Epidemiol Community Health 2000;54:444-50.
10. Perez-Perez GI, Salomaa A, Kosunen TU, Daverman B, Rautelin H, Aromaa A, et al. Evidence that cagA+ Helicobacter pylori strains are disappearing more rapidly than cagA+ strains. Gut 2002;50:295-8.
11. Aitkin M, Francis B, Hinde J. Statistical modelling in GLIM 4. 2nd ed. New York, NY: Oxford; 2005.
12. Blaser MJ. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 1999;179:1523-30.
13. Raderer M, Wrba F, Kornek G, Maca T, Koller DY, Weinlaender G, et al. Association between Helicobacter pylori infection and pancreatic cancer. Oncology 1998;55:16-9.
14. Wadström T, Fryzek JP, Demirjian S, Choi JW, Garabrant DH, Nyrén O, et al. Antibodies to Helicobacter bilis in patients with pancreatic carcinoma. Helicobacter 2004;9:538-9.
15. Kosunen TU, Pukkala E, Sarna S, Seppala K, Aromaa A, Knekt P, et al. Gastric cancers in Finnish patients after cure of Helicobacter pylori infection: a cohort study. Int J Cancer 2011;128: 433-9.
16. Lindkvist B, Johansen D, Borgström A, Manjer J. A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer. BMC Cancer 2008;8:321.
17. Gawin A, Wex T, Ławniczak M, Malfertheiner P, Starzyńska T. Zakaźenie Helicobacter pylori w raku trzustki. [Helicobacter pylori infection in pancreatic cancer (in Polish)] Pol Merkuriusz Lek 2012; 32:103-7.
18. Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, Perez-Perez G, Taylor PR, Virtamo J, et al. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst 2001;93: 937-41.
19. de Martel C, Llosa AE, Friedman GD, Vogelman JH, Orentreich N, Stolzenberg-Solomon RZ, et al. Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2008;17:1188-94.
20. Loh JT, Shaffer CL, Piazuelo MB, Bravo LE, McClain MS, Correa P, et al. Analysis of cagA in Helicobacter pylori strains from Colombian populations with contrasting gastric cancer risk reveals a biomarker for disease severity. Cancer Epidemiol Biomarkers Prev 2011;20: 2237-49.
21. Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A 2002;99:14428-33.
22. Atherton JC, Blaser MJ. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest 2009;119: 2475-87.
23. Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002;2:28-37.
24. Di Campli C, Nocente R, Costamagna G, Gentiloni N, Burioni R, Wu J, et al. Noevidence of Helicobacter pylori sequences in pancreatic juices of patients affected by chronic pancreatitis. Int J Pancreatol 2000;28:181-5.
25. Nilsson HO, Stenram U, Ihse I, Wadstrom T. Re: Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst 2002;94:632-3.
26. Jesenofsky R, Isaksson B, Möhrcke C, Bertsch C, Bulajic M, Schneider-Brachert W, et al. Helicobacter pylori in autoimmune pancreatitis and pancreatic carcinoma. Pancreatology 2010;10:462-6.
27. Moss SF, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut 1993;34:888-92.
28. Parente F, Maconi G, Sangaletti O, Minguzzi M, Vago L, Bianchi Porro G. Behaviour of acid secretion, gastrin release, serum pepsinogen I, and gastric emptying of liquids over six months from eradication of Helicobacter pylori in duodenal ulcer patients. A controlled study. Gut 1995;37:210-5.
29. Haruma K, Mihara M, Okamoto E, Kusunoki H, Hananoki M, Tanaka S, et al. Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus-evaluation of 24-h pH monitoring. Aliment Pharmacol Ther 1999;13: 155-62.
30. Howatson AG, Carter DC. Pancreatic carcinogenesis: effect of secretin in the hamster-nitrosamine model. J Natl Cancer Inst 1987;78:101-5.